JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/17.01.25 Stock

Warrant

DE000JL1KNN8

Market Closed - Börse Stuttgart 03:20:01 2024-06-14 am EDT
2.18 EUR +7.39% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./235/0.1/17.01.25
Current month-11.02%
1 month+1.40%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-14 2.18 +7.39%
24-06-13 2.03 -1.93%
24-06-12 2.07 +10.70%
24-06-11 1.87 0.00%
24-06-10 1.87 +3.31%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 03:20 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNN
ISINDE000JL1KNN8
Date issued 2023-04-05
Strike 235 $
Maturity 2025-01-17 (216 Days)
Parity 10 : 1
Emission price 1.91
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 3.47
Lowest since issue 1.75
Delta-0.43x
Omega 4.247
Premium9.51x
Gearing9.95x
Moneyness 1.005
Difference Strike 1.27 $
Difference Strike %+0.54%
Spread 0.15
Spread %6.61%
Theoretical value 2.195
Implied Volatility 35.62 %
Total Loss Probability 47.36 %
Intrinsic value 0.1186
Present value 2.076
Break even 211.50 €
Theta-0.03x
Vega0.07x
Rho-0.05x

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus